Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma

  • Authors:
    • Takehiko Ochiumi
    • Shinji Tanaka
    • Shiro Oka
    • Toru Hiyama
    • Masanori Ito
    • Yasuhiko Kitadai
    • Ken Haruma
    • Kazuaki Chayama
  • View Affiliations

  • Published online on: March 1, 2004     https://doi.org/10.3892/ijo.24.3.539
  • Pages: 539-547
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Angiopoietin (Ang)-2 and vascular endothelial growth factor (VEGF) are thought to be critical regulators in tumor angiogenesis. We investigated the clinical significance of Ang-2 expression at the deepest invasive tumor site under the influence of VEGF expression in relation to angiogenesis, invasive/metastatic potential, and prognosis of advanced colorectal carcinoma (CRC). One hundred and fifty-two patients who underwent surgical resection for advanced CRC were enrolled in this study. Ang-2 and VEGF expression were examined immunohistochemically. Tumor microvessel density (MVD) was examined by immunohistochemical staining against CD34. Ang-2 and VEGF were expressed at the deepest invasive tumor site in 90 (59.2%) and 64 (42.1%) of 152 lesions, respectively. Patients with Ang-2 expression at the deepest invasive tumor site showed significantly (p<0.01) more frequent poorly histologic grade (71.9%), lymphatic involvement (65.9%), venous involvement (69.1%), lymph node metastasis (75.0%), liver metastasis (80.0%) and advanced disease (Dukes' stage C, 70.2%; stage D, 80.0%) than patients without Ang-2 expression. MVD was not significantly up-regulated by Ang-2 expression alone at the deepest invasive tumor site but was significantly up-regulated by VEGF expression at the deepest invasive tumor site under the positive-Ang-2 condition. In patients treated by curative surgery, patients with tumors showing both positive-Ang-2 and positive-VEGF condition at the deepest invasive tumor site had significantly poorer prognoses than patients with tumors under other conditions. Multivariate analysis with logistic regression for 5-year survival in cases of curative surgery showed that lymph node metastasis, VEGF expression and Ang-2 expression were significant factors to predict poor prognosis. Our results suggest that Ang-2 expression in collaboration with VEGF expression at the deepest invasive tumor site may result in tumor angiogenesis and that these angiogenic factors at the deepest invasive tumor site may be correlated with invasive/malignant potential and prognosis of advanced CRC.

Related Articles

Journal Cover

March 2004
Volume 24 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ochiumi, T., Tanaka, S., Oka, S., Hiyama, T., Ito, M., Kitadai, Y. ... Chayama, K. (2004). Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma. International Journal of Oncology, 24, 539-547. https://doi.org/10.3892/ijo.24.3.539
MLA
Ochiumi, T., Tanaka, S., Oka, S., Hiyama, T., Ito, M., Kitadai, Y., Haruma, K., Chayama, K."Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma". International Journal of Oncology 24.3 (2004): 539-547.
Chicago
Ochiumi, T., Tanaka, S., Oka, S., Hiyama, T., Ito, M., Kitadai, Y., Haruma, K., Chayama, K."Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma". International Journal of Oncology 24, no. 3 (2004): 539-547. https://doi.org/10.3892/ijo.24.3.539